In vitro susceptibility and cellular uptake for a new class of antimicrobial agents: dinuclear ruthenium(II) complexes

Predicting the in Vivo Mechanism of Action for Drug Leads Using NMR Metabolomics

(2011) Steven Halouska et al.   ACS Chemical Biology

Resistance drives antibacterial drug development

(2011) Ursula Theuretzbacher   CURRENT OPINION IN PHARMACOLOGY

The antimicrobial activity of inert oligonuclear polypyridylruthenium(ii) complexes against pathogenic bacteria, including MRSA

(2011) Fangfei Li et al.   DALTON TRANSACTIONS

Oligonuclear polypyridylruthenium(ii) complexes incorporating flexible polar and non-polar bridges: synthesis, DNA-binding and cytotoxicity

(2011) Yanyan Mulyana et al.   DALTON TRANSACTIONS

Antimicrobial activity of ruthenium-based intercalators

(2010) Albert Bolhuis et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Selective mitochondrial accumulation of cytotoxic dinuclear polypyridyl ruthenium(ii) complexes

(2010) Michelle J. Pisani et al.   Metallomics

Electrochemical, catalytic and antimicrobial activity of N-functionalized tetraazamacrocyclic binuclear nickel(II) complexes

(2010) R. Prabu et al.   SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY

Synthesis, characterization and DNA binding and photocleavage studies of [Ru(bpy)2BDPPZ]2+, [Ru(dmb)2BDPPZ]2+and [Ru(phen)2BDPPZ]2+complexes and their antimicrobial activity

(2009) K. Ashwini Kumar et al.   APPLIED ORGANOMETALLIC CHEMISTRY

Antimicrobial activity of an iron triple helicate

(2009) Adair D. Richards et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

A ruthenium(II) polypyridyl complex for direct imaging of DNA structure in living cells

(2009) Martin R. Gill et al.   Nature Chemistry

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

(2008) Helen W. Boucher et al.   CLINICAL INFECTIOUS DISEASES